A citation-based method for searching scientific literature

Lauren Pickel, Ioan-Andrei Iliuta, James Scholey, York Pei, Hoon-Ki Sung. Adv Nutr 2021
Times Cited: 3







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.
Jacob A Torres, Samantha L Kruger, Caroline Broderick, Tselmeg Amarlkhagva, Shagun Agrawal, John R Dodam, Michal Mrug, Leslie A Lyons, Thomas Weimbs. Cell Metab 2019
57
66

Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
Kristen L Nowak, Zhiying You, Berenice Gitomer, Godela Brosnahan, Vicente E Torres, Arlene B Chapman, Ronald D Perrone, Theodore I Steinman, Kaleab Z Abebe, Frederic F Rahbari-Oskoui,[...]. J Am Soc Nephrol 2018
53
66

Food Restriction Ameliorates the Development of Polycystic Kidney Disease.
Gina Warner, Kyaw Zaw Hein, Veronica Nin, Marika Edwards, Claudia C S Chini, Katharina Hopp, Peter C Harris, Vicente E Torres, Eduardo N Chini. J Am Soc Nephrol 2016
88
66

A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.
Kevin R Kipp, Mina Rezaei, Louis Lin, Elyse C Dewey, Thomas Weimbs. Am J Physiol Renal Physiol 2016
45
66

Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Vicente E Torres, Kaleab Z Abebe, Robert W Schrier, Ronald D Perrone, Arlene B Chapman, Alan S Yu, William E Braun, Theodore I Steinman, Godela Brosnahan, Marie C Hogan,[...]. Kidney Int 2017
48
66

Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Vicente E Torres, Arlene B Chapman, Olivier Devuyst, Ron T Gansevoort, Jared J Grantham, Eiji Higashihara, Ronald D Perrone, Holly B Krasa, John Ouyang, Frank S Czerwiec. N Engl J Med 2012
862
66

National, regional, and global trends in adult overweight and obesity prevalences.
Gretchen A Stevens, Gitanjali M Singh, Yuan Lu, Goodarz Danaei, John K Lin, Mariel M Finucane, Adil N Bahalim, Russell K McIntire, Hialy R Gutierrez, Melanie Cowan,[...]. Popul Health Metr 2012
518
33

Distribution of renal medullary hyaluronan in lean and obese rabbits.
T M Dwyer, S A Banks, M Alonso-Galicia, K Cockrell, J F Carroll, S A Bigler, J E Hall. Kidney Int 2000
43
33

Obesity-related glomerulopathy: body mass index and proteinuria.
Wen-wen Shen, Hui-mei Chen, Hao Chen, Feng Xu, Lei-shi Li, Zhi-hong Liu. Clin J Am Soc Nephrol 2010
60
33

Obesity-induced hypertension. Renal function and systemic hemodynamics.
J E Hall, M W Brands, W N Dixon, M J Smith. Hypertension 1993
250
33

Physical inactivity: a risk factor and target for intervention in renal care.
Dorien M Zelle, Gerald Klaassen, Edwin van Adrichem, Stephan J L Bakker, Eva Corpeleijn, Gerjan Navis. Nat Rev Nephrol 2017
91
33


Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
Luis F Menezes, Cheng-Chao Lin, Fang Zhou, Gregory G Germino. EBioMedicine 2016
91
33


Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.
Xinmei Zhang, Dennis C Y Yeung, Michal Karpisek, David Stejskal, Zhi-Guang Zhou, Feng Liu, Rachel L C Wong, Wing-Sun Chow, Annette W K Tso, Karen S L Lam,[...]. Diabetes 2008
625
33

Obesity, hypertension, and chronic kidney disease.
Michael E Hall, Jussara M do Carmo, Alexandre A da Silva, Luis A Juncos, Zhen Wang, John E Hall. Int J Nephrol Renovasc Dis 2014
237
33

Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore.
Anoop Shankar, Chenlei Leng, Kee Seng Chia, David Koh, E Shyong Tai, Seang Mei Saw, Su Chi Lim, Tien Yin Wong. Nephrol Dial Transplant 2008
76
33

Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis.
Chenhan Ma, Alison Avenell, Mark Bolland, Jemma Hudson, Fiona Stewart, Clare Robertson, Pawana Sharma, Cynthia Fraser, Graeme MacLennan. BMJ 2017
201
33

The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy.
Gang Wei, Honglin Sun, Kai Dong, Libing Hu, Qi Wang, Qian Zhuang, Yan Zhu, Xianjing Zhang, Yaodi Shao, Huiru Tang,[...]. Cell Metab 2021
6
33

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.
Holly Kramer, Amy Luke, Anil Bidani, Guichan Cao, Richard Cooper, Dan McGee. Am J Kidney Dis 2005
264
33

FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue.
Yingyi Zhang, Jielu Hao, Mariana G Tarrago, Gina M Warner, Nino Giorgadze, Qing Wei, Yan Huang, Kai He, Chuan Chen, Thais R Peclat,[...]. Cell Rep 2021
4
33

Weight loss improves renal hemodynamics in patients with metabolic syndrome.
Danielle Guedes Andrade Ezequiel, Monica Barros Costa, Alfredo Chaoubah, Rogerio Baumgratz de Paula. J Bras Nefrol 2012
9
33

Overweight and sympathetic overactivity in black Americans.
N I Abate, Y H Mansour, M Tuncel, D Arbique, B Chavoshan, A Kizilbash, T Howell-Stampley, W Vongpatanasin, R G Victor. Hypertension 2001
85
33

Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.
Meredith C Foster, Shih-Jen Hwang, Joseph M Massaro, Udo Hoffmann, Ian H DeBoer, Sander J Robins, Ramachandran S Vasan, Caroline S Fox. Obesity (Silver Spring) 2011
72
33


Is obesity a major cause of chronic kidney disease?
John E Hall, Jeffrey R Henegar, Terry M Dwyer, Jiankang Liu, Alexandre A Da Silva, Jay J Kuo, Lakshmi Tallam. Adv Ren Replace Ther 2004
143
33

Association of visceral and subcutaneous adiposity with kidney function.
Jill A Young, Shih-Jen Hwang, Mark J Sarnak, Udo Hoffmann, Joseph M Massaro, Daniel Levy, Emelia J Benjamin, Martin G Larson, Ramachandran S Vasan, Christopher J O'Donnell,[...]. Clin J Am Soc Nephrol 2008
42
33

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.
J P Bastard, C Jardel, E Bruckert, P Blondy, J Capeau, M Laville, H Vidal, B Hainque. J Clin Endocrinol Metab 2000
750
33

Defining comorbidity: implications for understanding health and health services.
Jose M Valderas, Barbara Starfield, Bonnie Sibbald, Chris Salisbury, Martin Roland. Ann Fam Med 2009
765
33

Body mass index in 1.2 million adolescents and risk for end-stage renal disease.
Asaf Vivante, Eliezer Golan, Dorit Tzur, Adi Leiba, Amir Tirosh, Karl Skorecki, Ronit Calderon-Margalit. Arch Intern Med 2012
176
33

The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD.
Jonathan Freise, Mehdi Tavakol, Ying Gao, Oana Klein, Brian K Lee, Chris Freise, Meyeon Park. Kidney Int Rep 2019
3
33

Association between physical activity and mortality in end-stage kidney disease: a systematic review of observational studies.
Pedro Martins, Elisa A Marques, Diogo V Leal, Aníbal Ferreira, Kenneth R Wilund, João L Viana. BMC Nephrol 2021
8
33

Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
Alex Chang, Linda Van Horn, David R Jacobs, Kiang Liu, Paul Muntner, Britt Newsome, David A Shoham, Ramon Durazo-Arvizu, Kirsten Bibbins-Domingo, Jared Reis,[...]. Am J Kidney Dis 2013
95
33

Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.
Meredith C Foster, Shih-Jen Hwang, Stacy A Porter, Joseph M Massaro, Udo Hoffmann, Caroline S Fox. Hypertension 2011
192
33

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Muftah Othman, Bisher Kawar, A Meguid El Nahas. Nephron Clin Pract 2009
77
33

Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease.
Thomas Weimbs, Jonathan M Shillingford, Jacob Torres, Samantha L Kruger, Bryan C Bourgeois. Clin Kidney J 2018
16
33


Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients.
Frank Fung, Donald J Sherrard, Daniel L Gillen, Craig Wong, Bryan Kestenbaum, Steven Seliger, Adrianne Ball, Catherine Stehman-Breen. Am J Kidney Dis 2002
107
33

Polycystic kidney disease.
Carsten Bergmann, Lisa M Guay-Woodford, Peter C Harris, Shigeo Horie, Dorien J M Peters, Vicente E Torres. Nat Rev Dis Primers 2018
201
33


Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kyoungmi Kim, Josephine F Trott, Guimin Gao, Arlene Chapman, Robert H Weiss. BMC Nephrol 2019
8
33

Mechanisms of obesity-associated cardiovascular and renal disease.
John E Hall, Errol D Crook, Daniel W Jones, Marion R Wofford, Patricia M Dubbert. Am J Med Sci 2002
227
33


Serum immunoreactive-leptin concentrations in normal-weight and obese humans.
R V Considine, M K Sinha, M L Heiman, A Kriauciunas, T W Stephens, M R Nyce, J P Ohannesian, C C Marco, L J McKee, T L Bauer. N Engl J Med 1996
33

Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016.
Fouad T Chebib, Vicente E Torres. Am J Kidney Dis 2016
121
33

Association between obesity and kidney disease: a systematic review and meta-analysis.
Y Wang, X Chen, Y Song, B Caballero, L J Cheskin. Kidney Int 2008
384
33

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
Kamyar Kalantar-Zadeh, Gladys Block, Michael H Humphreys, Joel D Kopple. Kidney Int 2003
862
33





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.